25Jan
Financial Daily Dose 1.25.2021 | Top Story: Merck Abandons Covid Vaccine Effort Over Ineffective Results
U.S. drug giant Merck is shuttering its coronavirus vaccine development “after early trial data showed [its pair of vaccines] failed to generate immune responses comparable to natural infection or existing vaccines.”...
By:
Robins Kaplan LLP
Related
A new guidance letter from the Occupational Safety and Health Administration (OSHA) states it is leg...
Read More >
TRENDS IN ESG, SRI AND IMPACT INVESTING - - Investors are increasingly focused on Environmental, So...
Read More >
Read the latest news on antitrust, competition and economic regulation (ACER) in this Spring's editi...
Read More >
Over the summer, we wrote about why health care companies may want to consider buying assets out of ...
Read More >
Due to the developing COVID-19 coronavirus pandemic, beginning Tuesday, March 17, 2020, the Federal ...
Read More >
Conflict exists between every generation, at least to some degree, and this is not new. Advancements...
Read More >